Literature DB >> 22683139

Hypoalbuminemia in the first 24h of admission is associated with organ dysfunction in burned patients.

Roberto Eljaiek1, Marc-Jacques Dubois.   

Abstract

OBJECTIVE: Hypoalbuminemia is a common finding in burned patients, but its association with increased morbidity and mortality has not been well established. We assessed whether hypoalbuminemia in the first 24h of admission is associated with organ dysfunction in patients with severe burns.
METHODS: For a two year period (2008-2009), we reviewed the records of burn adult patients with a total body surface area 20% admitted in our unit within the first 24h of injury. A multiple linear regression analysis was conducted to assess hypoalbuminemia as an independent predictor of organ dysfunction.
RESULTS: 56 subjects were analyzed. Multiple linear regression analysis showed that hypoalbuminemia in the first 24h of admission was an independent predictor of organ dysfunction. Serum albumin concentration ≤ 30 g/L was associated with a two-fold increase in organ dysfunction [SOFA scores at day 0 (p=0.005), day 1 (p=0.005) and first week mean values (p=0.004)], but not with mortality (p=0.061).
CONCLUSION: Hypoalbuminemia is associated with organ dysfunction in burned patients. Unlike unmodifiable predictors such as age, burn surface and inhalation burn, correction of hypoalbuminemia might represent a goal for a future trial in burn patients.
Copyright © 2012 Elsevier Ltd and ISBI. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22683139     DOI: 10.1016/j.burns.2012.05.008

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  8 in total

1.  Rhabdomyolysis, compartment syndrome and thermal injury.

Authors:  Yusuf Kenan Coban
Journal:  World J Crit Care Med       Date:  2014-02-04

Review 2.  Overview of Albumin and Its Purification Methods.

Authors:  Ramin Raoufinia; Ali Mota; Neda Keyhanvar; Fatemeh Safari; Sara Shamekhi; Jalal Abdolalizadeh
Journal:  Adv Pharm Bull       Date:  2016-12-22

3.  A Risk Model and Cost Analysis of Incisional Hernia After Elective, Abdominal Surgery Based Upon 12,373 Cases: The Case for Targeted Prophylactic Intervention.

Authors:  John P Fischer; Marten N Basta; Michael N Mirzabeigi; Andrew R Bauder; Justin P Fox; Jeffrey A Drebin; Joseph M Serletti; Stephen J Kovach
Journal:  Ann Surg       Date:  2016-05       Impact factor: 12.969

4.  Serum albumin levels and their correlates among individuals with motor disorders at five institutions in Japan.

Authors:  Hiroko Ohwada; Takeo Nakayama; Yuki Kanaya; Yuki Tanaka
Journal:  Nutr Res Pract       Date:  2017-01-26       Impact factor: 1.926

5.  Predictors of Early Onset Multiple Organ Dysfunction in Major Burn Patients with Ventilator Support: Experience from A Mass Casualty Explosion.

Authors:  Jia-Yih Feng; Jung-Yien Chien; Kuo-Chin Kao; Cheng-Liang Tsai; Fang Ming Hung; Fan-Min Lin; Han-Chung Hu; Kun-Lun Huang; Chong-Jen Yu; Kuang-Yao Yang
Journal:  Sci Rep       Date:  2018-07-19       Impact factor: 4.379

6.  Investigating factors affecting the interval between a burn and the start of treatment using data mining methods and logistic regression.

Authors:  Touraj Ahmadi-Jouybari; Somayeh Najafi-Ghobadi; Reza Karami-Matin; Saeid Najafian-Ghobadi; Khadijeh Najafi-Ghobadi
Journal:  BMC Med Res Methodol       Date:  2021-04-14       Impact factor: 4.615

7.  Investigation of red cell distribution width as a prognostic criterion in severe burns.

Authors:  Mehmet Fatih Akkoç; Semra Bülbüloğlu
Journal:  Int Wound J       Date:  2021-12-14       Impact factor: 3.099

8.  Serum albumin level as a risk factor for mortality in burn patients.

Authors:  Olivia Alejandra Aguayo-Becerra; Carlos Torres-Garibay; Michel Dassaejv Macías-Amezcua; Clotilde Fuentes-Orozco; Mariana de Guadalupe Chávez-Tostado; Elizabeth Andalón-Dueñas; Arturo Espinosa Partida; Andrea Del Socorro Alvarez-Villaseñor; Ana Olivia Cortés-Flores; Alejandro González-Ojeda
Journal:  Clinics (Sao Paulo)       Date:  2013-07       Impact factor: 2.365

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.